Leukemia, Myeloid, Acute

Showing NaN - NaN of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Oral Azacitidine
  • Placebo
  • Phoenix, Arizona
  • +247 more
Jan 13, 2023

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Duarte, California
  • +72 more
Aug 18, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +94 more
Jun 9, 2022

Leukemia, Myeloid, Acute Trial in United States (CPX-351, Quizartinib)

Terminated
  • Leukemia, Myeloid, Acute
  • Denver, Colorado
  • +4 more
May 10, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

Terminated
  • Leukemia, Myeloid, Acute
  • AML
  • Aurora, Colorado
  • +16 more
Jan 18, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (glasdegib, daunorubicin + cytarabine, azacitidine)

Completed
  • Leukemia, Myeloid, Acute
  • Los Angeles, California
  • +148 more
Jan 24, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (Placebo, Volasertib, Cytarabine)

Completed
  • Leukemia, Myeloid, Acute
  • Placebo
  • +2 more
  • Los Angeles, California
  • +121 more
Oct 25, 2021

Leukemia, Myeloid, Acute Trial in Spain, United States (JNJ-63709178)

Completed
  • Leukemia, Myeloid, Acute
  • Detroit, Michigan
  • +9 more
Aug 30, 2021

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)

Terminated
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Boston, Massachusetts
  • +5 more
Jun 11, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    Leukemia, Myeloid, Acute Trial in Worldwide (SGI-110 (guadecitabine), Treatment Choice)

    Completed
    • Leukemia, Myeloid, Acute
    • SGI-110 (guadecitabine)
    • Treatment Choice
    • Scottsdale, Arizona
    • +134 more
    Dec 21, 2020

    Leukemia, Myeloid, Acute Trial in United States (PNK-007, Cyclophosphamide, Fludarabine)

    Terminated
    • Leukemia, Myeloid, Acute
    • PNK-007
    • +3 more
    • Boston, Massachusetts
    • +6 more
    Jul 20, 2020

    Leukemia, Myeloid, Acute Trial in Worldwide (AC220)

    Completed
    • Leukemia, Myeloid, Acute
    • Los Angeles, California
    • +23 more
    Dec 20, 2019

    MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in United States (oral azacitidine)

    Completed
    • Myelodysplastic Syndromes
    • +2 more
    • oral azacitidine
    • La Jolla, California
    • +7 more
    Nov 7, 2019

    Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine 20 mg/m^2, Talacotuzumab 9 mg/kg)

    Completed
    • Leukemia, Myeloid, Acute
    • Decitabine 20 mg/m^2
    • Talacotuzumab 9 mg/kg
    • Orange, California
    • +80 more
    Mar 11, 2019

    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States

    Completed
    • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
    • +5 more
    • Haploidentical Bone Marrow Transplantation
    • GVHD prophylaxis
    • Duarte, California
    • +16 more
    Nov 28, 2017